Bioventus (BVS) Change in Receivables (2020 - 2026)

Bioventus has reported Change in Receivables for 7 years, with the latest figure at -$7.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables rose 18.73% year-over-year to -$7.3 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (up 979.05% YoY), and the FY2025 full-year result was $916000.0, down 91.41% from the prior year.
• Change in Receivables for Q1 2026 stood at -$7.3 million, down from -$1.9 million in the prior quarter.
• The five-year high for Change in Receivables was $25.6 million in Q3 2022, with the low at -$17.1 million in Q3 2024.
• Historically, Change in Receivables has averaged $698882.4 across 5 years, with a median of -$1.8 million in 2025.
• Annual changes were most pronounced in 2024 — Change in Receivables soared 989.74% — and 2025, when it sank 559.86%.
• Bioventus' Change in Receivables stood at $4.8 million in 2022, then soared by 90.23% to $9.2 million in 2023, then tumbled by 36.99% to $5.8 million in 2024, then slumped by 132.54% to -$1.9 million in 2025, then sank by 288.22% to -$7.3 million in 2026.
• The last three Change in Receivables figures came in at -$7.3 million (Q1 2026), -$1.9 million (Q4 2025), and -$1.8 million (Q3 2025), per Business Quant data.